138 related articles for article (PubMed ID: 11181122)
21. Prognostic factors for nosocomial bacteraemia outcome: a prospective study in a Greek teaching hospital.
Arvanitidou M; Katikaridou E; Douboyas J; Tsakris A
J Hosp Infect; 2005 Nov; 61(3):219-24. PubMed ID: 16039015
[TBL] [Abstract][Full Text] [Related]
22. Institutional perspective on the impact of positive blood cultures on the economic and clinical outcomes of patients with complicated skin and skin structure infections: focus on gram-positive infections.
Micek ST; Hoban AP; Pham V; Doherty JA; Kollef MH
Clin Ther; 2011 Nov; 33(11):1759-1768.e1. PubMed ID: 22001358
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.
McNeil SA; Malani PN; Chenoweth CE; Fontana RJ; Magee JC; Punch JD; Mackin ML; Kauffman CA
Clin Infect Dis; 2006 Jan; 42(2):195-203. PubMed ID: 16355329
[TBL] [Abstract][Full Text] [Related]
24. Bacteremia in previously hospitalized patients: prolonged effect from previous hospitalization and risk factors for antimicrobial-resistant bacterial infections.
Chen SY; Wu GH; Chang SC; Hsueh PR; Chiang WC; Lee CC; Ma MH; Hung CC; Chen YC; Su CP; Tsai KC; Chen TH; Chen SC; Chen WJ
Ann Emerg Med; 2008 May; 51(5):639-46. PubMed ID: 18353506
[TBL] [Abstract][Full Text] [Related]
25. [Nosocomial enterococcal bacteremia].
Pallarés R; Barberá MJ; Guillamont J
Rev Clin Esp; 1995 Oct; 195 Suppl 4():12-5. PubMed ID: 9441310
[No Abstract] [Full Text] [Related]
26. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.
Schwaber MJ; Navon-Venezia S; Kaye KS; Ben-Ami R; Schwartz D; Carmeli Y
Antimicrob Agents Chemother; 2006 Apr; 50(4):1257-62. PubMed ID: 16569837
[TBL] [Abstract][Full Text] [Related]
27. Attributable mortality of Stenotrophomonas maltophilia bacteremia.
Senol E; DesJardin J; Stark PC; Barefoot L; Snydman DR
Clin Infect Dis; 2002 Jun; 34(12):1653-6. PubMed ID: 12032905
[TBL] [Abstract][Full Text] [Related]
28. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.
Zaoutis TE; Argon J; Chu J; Berlin JA; Walsh TJ; Feudtner C
Clin Infect Dis; 2005 Nov; 41(9):1232-9. PubMed ID: 16206095
[TBL] [Abstract][Full Text] [Related]
29. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
[TBL] [Abstract][Full Text] [Related]
30. How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia.
Bates DW; Pruess KE; Lee TH
Arch Intern Med; 1995 Mar; 155(6):593-8. PubMed ID: 7887754
[TBL] [Abstract][Full Text] [Related]
31. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
[TBL] [Abstract][Full Text] [Related]
32. Vancomycin-resistant enterococcal bloodstream infection-related mortality: focus on the lack of appropriate therapy.
Nannini EC
Clin Infect Dis; 2006 Apr; 42(8):1203-4; author reply 1204-5. PubMed ID: 16575743
[No Abstract] [Full Text] [Related]
33. Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.
Shorr AF; Tabak YP; Killian AD; Gupta V; Liu LZ; Kollef MH
Crit Care Med; 2006 Oct; 34(10):2588-95. PubMed ID: 16915117
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
[TBL] [Abstract][Full Text] [Related]
35. Risk factors and outcomes associated with non-Enterococcus faecalis, non-Enterococcus faecium enterococcal bacteremia.
de Perio MA; Yarnold PR; Warren J; Noskin GA
Infect Control Hosp Epidemiol; 2006 Jan; 27(1):28-33. PubMed ID: 16418983
[TBL] [Abstract][Full Text] [Related]
36. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection.
Khatib R; Riederer K; Saeed S; Johnson LB; Fakih MG; Sharma M; Tabriz MS; Khosrovaneh A
Clin Infect Dis; 2005 Sep; 41(5):594-8. PubMed ID: 16080079
[TBL] [Abstract][Full Text] [Related]
37. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.
Vergis EN; Hayden MK; Chow JW; Snydman DR; Zervos MJ; Linden PK; Wagener MM; Schmitt B; Muder RR
Ann Intern Med; 2001 Oct; 135(7):484-92. PubMed ID: 11578151
[TBL] [Abstract][Full Text] [Related]
38. Enterococcal meningitis: a clinical study of 39 cases and review of the literature.
Pintado V; Cabellos C; Moreno S; Meseguer MA; Ayats J; Viladrich PF
Medicine (Baltimore); 2003 Sep; 82(5):346-64. PubMed ID: 14530784
[TBL] [Abstract][Full Text] [Related]
39. [Community-acquired bacteremia].
Cisterna R; Cabezas V; Gómez E; Busto C; Atutxa I; Ezpeleta C
Rev Esp Quimioter; 2001 Dec; 14(4):369-82. PubMed ID: 11856984
[TBL] [Abstract][Full Text] [Related]
40. Endocarditis in burn patients: clinical and diagnostic considerations.
Regules JA; Glasser JS; Wolf SE; Hospenthal DR; Murray CK
Burns; 2008 Aug; 34(5):610-6. PubMed ID: 18029099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
